About Solid Biosciences
Solid Biosciences is a company based in Cambridge (United States) founded in 2014.. Solid Biosciences has raised $92.5 million across 6 funding rounds from investors including Biogen, Janus Henderson Investors and RTW Investments. The company has 100 employees as of December 31, 2024. Solid Biosciences has completed 1 acquisition, including AAVANTIBio. Solid Biosciences offers products and services including Gene Therapy Candidates and Genetic Regulators Library. Solid Biosciences operates in a competitive market with competitors including Jazz Pharmaceuticals, Denali Therapeutics, Spark Therapeutics, MiRagen and Lundbeck, among others.
- Headquarter Cambridge, United States
- Employees 100 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Solid Biosciences Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-124.7 M-29.87as on Dec 31, 2024
-
EBITDA
$-127.27 M-25.1as on Dec 31, 2024
-
Total Equity Funding
$92.5 M (USD)
in 6 rounds
-
Latest Funding Round
$108.9 M (USD), Post-IPO
Jan 08, 2024
-
Investors
Biogen
& 15 more
-
Employee Count
100
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Solid Biosciences
Solid Biosciences is a publicly listed company on the NASDAQ with ticker symbol SLDB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Solid Biosciences
Solid Biosciences offers a comprehensive portfolio of products and services, including Gene Therapy Candidates and Genetic Regulators Library. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments targeting rare neuromuscular diseases
Tools to enhance gene therapy delivery methods
Unlock access to complete
Unlock access to complete
Funding Insights of Solid Biosciences
Solid Biosciences has successfully raised a total of $92.5M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $108.9 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $108.9M
-
First Round
First Round
(03 Nov 2015)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Post-IPO - Solid Biosciences | Valuation |
investors |
|
| Dec, 2020 | Amount | Post-IPO - Solid Biosciences | Valuation |
investors |
|
| Oct, 2020 | Amount | Post-IPO - Solid Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Solid Biosciences
Solid Biosciences has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Biogen, Janus Henderson Investors and RTW Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Solid Biosciences
Solid Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AAVANTIBio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene transfer therapies for neuromuscular diseases are developed.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Solid Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Solid Biosciences Comparisons
Competitors of Solid Biosciences
Solid Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Denali Therapeutics, Spark Therapeutics, MiRagen and Lundbeck, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Solid Biosciences
Frequently Asked Questions about Solid Biosciences
When was Solid Biosciences founded?
Solid Biosciences was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Solid Biosciences located?
Solid Biosciences is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Solid Biosciences a funded company?
Solid Biosciences is a funded company, having raised a total of $92.5M across 6 funding rounds to date. The company's 1st funding round was a Post-IPO of $40M, raised on Nov 03, 2015.
How many employees does Solid Biosciences have?
As of Dec 31, 2024, the latest employee count at Solid Biosciences is 100.
What does Solid Biosciences do?
Solid Biosciences was founded in 2014 and is headquartered in Cambridge, United States. Focus is placed on biotechnology, specifically the development of gene therapy solutions for Duchenne muscular dystrophy. The primary candidate, SGT-001, features Microdystrophin, a synthetic dystrophin gene engineered to stabilize muscle membranes and the dystrophin-glycoprotein complex. A soft wearable device is also produced to support mobility and maintain muscle function for patients.
Who are the top competitors of Solid Biosciences?
Solid Biosciences's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and Sana Biotechnology.
What products or services does Solid Biosciences offer?
Solid Biosciences offers Gene Therapy Candidates and Genetic Regulators Library.
Is Solid Biosciences publicly traded?
Yes, Solid Biosciences is publicly traded on NASDAQ under the ticker symbol SLDB.
How many acquisitions has Solid Biosciences made?
Solid Biosciences has made 1 acquisition, including AAVANTIBio.
Who are Solid Biosciences's investors?
Solid Biosciences has 16 investors. Key investors include Biogen, Janus Henderson Investors, RTW Investments, RA Capital, and Perceptive Advisors.
What is Solid Biosciences's ticker symbol?
The ticker symbol of Solid Biosciences is SLDB on NASDAQ.